AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 40584 — intervention group
Group type: EXPERIMENTAL
Intervention: H1 receptor antagonist chlorpheniramine
Number of subjects: 10
Study 40584 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31587493 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT with active formulation cream (licochalcone A, L-carnitine, and decanediol)
Number of subjects: 29
Study 31587493 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT with active formulation cream
Number of subjects: 29
Study 31587493 — intervention group
Group type: COMPARATOR
Intervention: PDT with vehicle cream
Number of subjects: 29
Study 30971229 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 63
Study 30971229 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 28808723 — intervention group
Group type: EXPERIMENTAL
Intervention: High glycemic load diet
Number of subjects: 80
Study 28808723 — intervention group
Group type: COMPARATOR
Intervention: Low glycemic load diet
Number of subjects: 80
Study 26049662 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia
Number of subjects: 322
Study 26049662 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 322
Study 23810356 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 66
Study 23810356 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular exercise
Number of subjects: 66
Study 23810356 — intervention group
Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 66
Study 21696114 — intervention group
Group type: EXPERIMENTAL
Intervention: Gold brackets
Number of subjects: 40
Study 21696114 — intervention group
Group type: EXPERIMENTAL
Intervention: Stainless steel brackets
Number of subjects: 40
Study 21696114 — intervention group
Group type: COMPARATOR
Intervention: Plastic brackets
Number of subjects: 40
Study 21696114 — intervention group
Group type: COMPARATOR
Intervention: Ceramic brackets
Number of subjects: 40
Study 21696114 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hygiene indices (VPI and GBI)
Number of subjects: 40
Study 19432036 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent balneotherapy in a sulfur pool heated to 35-36 degrees C, twice weekly for 6 weeks
Number of subjects: 44
Study 19432036 — intervention group
Group type: COMPARATOR
Intervention: Control group treated in a Jacuzzi filled with tap water heated to 35-36 degrees C
Number of subjects: 44
Study 16442957 — intervention group
Group type: EXPERIMENTAL
Intervention: Didactic lecture followed by instructional SP interaction (Group A)
Number of subjects: 143
Study 16442957 — intervention group
Group type: COMPARATOR
Intervention: Instructional SP interaction followed by didactic lecture (Group B)
Number of subjects: 143
Study 15564181 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel node lymphadenectomy
Number of subjects: 100
Study 15564181 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 100
Study 11401935 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferoxamine (500 mg intra-arterially over 1 hour)
Number of subjects: 0
Study 11401935 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy subjects)
Number of subjects: 0
Study 11401935 — intervention group
Group type: COMPARATOR
Intervention: Control (normal volunteers)
Number of subjects: 0
Study 9207772 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass-ionomer restorations
Number of subjects: 666
Study 9207772 — intervention group
Group type: COMPARATOR
Intervention: Amalgam restorations
Number of subjects: 666
Study 9207772 — intervention group
Group type: COMPARATOR
Intervention: Surfaces adjacent to amalgam restorations
Number of subjects: 666
Study 9207772 — intervention group
Group type: EXPERIMENTAL
Intervention: Surfaces adjacent to glass-ionomer restorations
Number of subjects: 666
Study 8010314 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ondansetron
Number of subjects: 0
Study 8010314 — intervention group
Group type: COMPARATOR
Intervention: Combination of dexamethasone and metoclopramide
Number of subjects: 0
Study 3191941 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 8
Study 3191941 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 30117361 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief education group (one‐page double‐sided document)
Number of subjects: 255
Study 30117361 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer education group (10‐page document)
Number of subjects: 255
Study 30117361 — intervention group
Group type: COMPARATOR
Intervention: Usual care (standard ED discharge instructions)
Number of subjects: 255
Study 30117361 — intervention group
Group type: COMPARATOR
Intervention: Trauma control group (non‐concussion)
Number of subjects: 255
Study 27836586 — intervention group
Group type: EXPERIMENTAL
Intervention: IUD insertion (either levonorgestrel-releasing intrauterine system or copper-IUD) offered at follow-up visit 1-4 weeks after MTOP.
Number of subjects: 606
Study 27836586 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for presumed adverse events (administration of antibiotics, misoprostol or surgical evacuation).
Number of subjects: 606
Study 27836586 — intervention group
Group type: EXPERIMENTAL
Intervention: IUD expulsion rate in the intervention group.
Number of subjects: 606
Study 27836586 — intervention group
Group type: COMPARATOR
Intervention: Control group follow-up and contraceptive provision.
Number of subjects: 606
Study 27836586 — intervention group
Group type: COMPARATOR
Intervention: Treatment for presumed adverse events in the control group.
Number of subjects: 606
Study 27836586 — intervention group
Group type: COMPARATOR
Intervention: Timing of adverse events in the control group.
Number of subjects: 606
Study 25084740 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART)
Number of subjects: 99
Study 25084740 — intervention group
Group type: COMPARATOR
Intervention: Conventional restorative technique (CT)
Number of subjects: 99
Study 25084740 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ART and CT
Number of subjects: 99
Study 23313352 — intervention group
Group type: EXPERIMENTAL
Intervention: 15° tilt-in-space and 120° recline
Number of subjects: 11
Study 23313352 — intervention group
Group type: EXPERIMENTAL
Intervention: 25° tilt-in-space and 120° recline
Number of subjects: 11
Study 23313352 — intervention group
Group type: EXPERIMENTAL
Intervention: 35° tilt-in-space and 120° recline
Number of subjects: 11
Study 23313352 — intervention group
Group type: EXPERIMENTAL
Intervention: 35° tilt-in-space and 100° recline
Number of subjects: 11
Study 23313352 — intervention group
Group type: EXPERIMENTAL
Intervention: 15° tilt-in-space and 100° recline
Number of subjects: 11
Study 23313352 — intervention group
Group type: EXPERIMENTAL
Intervention: 25° tilt-in-space and 100° recline
Number of subjects: 11
Study 21456091 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant applied before wound closure
Number of subjects: 74
Study 21456091 — intervention group
Group type: COMPARATOR
Intervention: Standard wound closure (Control)
Number of subjects: 74
Study 19318293 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol plus ondansetron (H+O)
Number of subjects: 210
Study 19318293 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol (H)
Number of subjects: 210
Study 19318293 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron (O)
Number of subjects: 210
Study 16676340 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation and stress management training to caregivers
Number of subjects: 22
Study 16676340 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 22
Study 15257785 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-evaluation with the expectation to improve
Number of subjects: 0
Study 15257785 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-evaluation without the expectation to improve
Number of subjects: 0
Study 11403977 — intervention group
Group type: EXPERIMENTAL
Intervention: Buserelin (low dose gonadotropin releasing hormone agonist)
Number of subjects: 0
Study 11403977 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11403977 — intervention group
Group type: COMPARATOR
Intervention: Untreated PMDD patients
Number of subjects: 0
Study 11403977 — intervention group
Group type: EXPERIMENTAL
Intervention: Buserelin treatment
Number of subjects: 0
Study 11403977 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 0
Study 9423389 — intervention group
Group type: EXPERIMENTAL
Intervention: Transparent dressing and StatLock i.v./PICC
Number of subjects: 105
Study 9423389 — intervention group
Group type: COMPARATOR
Intervention: Transparent dressing and tape (control group)
Number of subjects: 105
Study 8214647 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine (30 ng.kg‐1.min‐1)
Number of subjects: 40
Study 8214647 — intervention group
Group type: EXPERIMENTAL
Intervention: Amrinone (1.5 mg/kg)
Number of subjects: 40
Study 8214647 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of amrinone and epinephrine
Number of subjects: 40
Study 8214647 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 2871915 — intervention group
Group type: EXPERIMENTAL
Intervention: System of care with medical assistant overseeing screening and education (experimental group)
Number of subjects: 32124
Study 2871915 — intervention group
Group type: COMPARATOR
Intervention: Usual practices (control group)
Number of subjects: 32124
Study 28669606 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 minutes per week of aerobic exercise (low-dose)
Number of subjects: 39
Study 28669606 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 minutes per week of aerobic exercise (high-dose)
Number of subjects: 39
Study 28669606 — intervention group
Group type: COMPARATOR
Intervention: Usual-care control
Number of subjects: 39
Study 27391774 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialytic exercise programme (30 min continuous cycling thrice weekly during dialysis)
Number of subjects: 130
Study 27391774 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 130
Study 27391774 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialytic exercise programme
Number of subjects: 130
Study 24215215 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of azithromycin (AZM)
Number of subjects: 0
Study 24215215 — intervention group
Group type: COMPARATOR
Intervention: Intravenous administration of cefazolin (CEZ)
Number of subjects: 0
Study 24215215 — intervention group
Group type: EXPERIMENTAL
Intervention: Both AZM and CEZ
Number of subjects: 0
Study 22334806 — intervention group
Group type: EXPERIMENTAL
Intervention: Unattended polysomnography at baseline and auto-titrating CPAP therapy for up to one year
Number of subjects: 318
Study 22334806 — intervention group
Group type: COMPARATOR
Intervention: Usual care and unattended polysomnography at the end of the study
Number of subjects: 318
Study 21521204 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan-naproxen sodium (85 mg sumatriptan and 500 mg naproxen sodium)
Number of subjects: 0
Study 21521204 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 21521204 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan-naproxen sodium
Number of subjects: 0
Study 18357500 — intervention group
Group type: EXPERIMENTAL
Intervention: Stanger bath therapy and exercise program (n = 30)
Number of subjects: 58
Study 18357500 — intervention group
Group type: COMPARATOR
Intervention: Conventional exercise program alone (n = 28)
Number of subjects: 58
Study 16522454 — intervention group
Group type: EXPERIMENTAL
Intervention: FSC 100/50 microg twice daily
Number of subjects: 641
Study 16522454 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) 250 microg twice daily
Number of subjects: 641
Study 12694138 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedation with propofol
Number of subjects: 18
Study 12694138 — intervention group
Group type: COMPARATOR
Intervention: No sedation
Number of subjects: 18
Study 11075843 — intervention group
Group type: EXPERIMENTAL
Intervention: Rizatriptan wafer 10 mg
Number of subjects: 39
Study 11075843 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 8792758 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT) with high dosage and bilateral electrode placement
Number of subjects: 62
Study 8792758 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT) with low dosage and right unilateral electrode placement
Number of subjects: 62
Study 8792758 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 62
Study 1641599 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime
Number of subjects: 22
Study 1641599 — intervention group
Group type: EXPERIMENTAL
Intervention: Aztreonam
Number of subjects: 22
Study 6689302 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 14
Study 6689302 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepine
Number of subjects: 14
Study 6689302 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 14
Study 31079057 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5 mg
Number of subjects: 941
Study 31590426 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyano-B12 (CN-B12) capsules (2 × 2.8 µg/day)
Number of subjects: 35
Study 31590426 — intervention group
Group type: COMPARATOR
Intervention: Whey powder with endogenous hydroxo-B12 (HO-B12)
Number of subjects: 35
Study 31590426 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyano-B12 (CN-B12) capsules
Number of subjects: 35
Study 29911775 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver nanoparticle gel with 2.5% benzoyl peroxide
Number of subjects: 64
Study 29911775 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin gel with 2.5% benzoyl peroxide
Number of subjects: 64
Study 25761508 — intervention group
Group type: EXPERIMENTAL
Intervention: Pupillometry variables (LED light stimulus test)
Number of subjects: 384
Study 25761508 — intervention group
Group type: COMPARATOR
Intervention: Cardiac autonomic neuropathy diagnosis
Number of subjects: 384
Study 24321620 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk very preterm infants
Number of subjects: 82
Study 24321620 — intervention group
Group type: COMPARATOR
Intervention: Normal term infants
Number of subjects: 82
Study 24321620 — intervention group
Group type: COMPARATOR
Intervention: Low-risk very preterm infants
Number of subjects: 82
Study 23041227 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring system (CGMS)
Number of subjects: 0
Study 23041227 — intervention group
Group type: COMPARATOR
Intervention: Finger-stick blood glucose (FSBG)
Number of subjects: 0
Study 19402373 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin analogs (SSAs)
Number of subjects: 0
Study 17580443 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (Xingnao Kaiqiao Zhenfa)
Number of subjects: 256
Study 17580443 — intervention group
Group type: COMPARATOR
Intervention: Medication (Amitriptyline 50 mg/d initially, increased to 200 mg/d)
Number of subjects: 256
Study 17580443 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 256
Study 17580443 — intervention group
Group type: COMPARATOR
Intervention: Medication
Number of subjects: 256
Study 15064253 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized test battery
Number of subjects: 50
Study 15064253 — intervention group
Group type: COMPARATOR
Intervention: Conventional test battery
Number of subjects: 50
Study 11523414 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 68
Study 11523414 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 9934405 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (40 mcg) inhaled before the methacholine test
Number of subjects: 16
Study 9934405 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention mentioned)
Number of subjects: 16
Study 7921716 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 40
Study 7921716 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31965573 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypovolaemic phlebotomy (7-10 ml per kg whole blood removed, without intravenous fluid replacement)
Number of subjects: 62
Study 31965573 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 62
Study 31965573 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypovolaemic phlebotomy
Number of subjects: 62
Study 31965573 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypovolaemic phlebotomy (high-risk patients)
Number of subjects: 62
Study 31965573 — intervention group
Group type: COMPARATOR
Intervention: Standard care (high-risk patients)
Number of subjects: 62
Study 31302049 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate to severe malnutrition risk (GNRI <92)
Number of subjects: 1677
Study 31302049 — intervention group
Group type: EXPERIMENTAL
Intervention: Low malnutrition risk (GNRI 92 to <98)
Number of subjects: 1677
Study 31302049 — intervention group
Group type: COMPARATOR
Intervention: Absence of malnutrition risk (GNRI ≥98)
Number of subjects: 1677
Study 28060581 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group (n = 20)
Number of subjects: 404
Study 28060581 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 18)
Number of subjects: 404
Study 28060581 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 404
Study 25943048 — intervention group
Group type: EXPERIMENTAL
Intervention: Penetrating keratoplasty (PK)
Number of subjects: 15
Study 25943048 — intervention group
Group type: COMPARATOR
Intervention: Descemet stripping automated endothelial keratoplasty (DSAEK)
Number of subjects: 15
Study 25943048 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient satisfaction
Number of subjects: 15
Study 25943048 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient preference for better performing eye
Number of subjects: 15
Study 24643490 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention B (60 hours of physical activities)
Number of subjects: 62
Study 24643490 — intervention group
Group type: COMPARATOR
Intervention: Intervention A (40 hours of physical activities)
Number of subjects: 62
Study 24643490 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 62
Study 24643490 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention B
Number of subjects: 62
Study 21451952 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg/day
Number of subjects: 679
Study 18061648 — intervention group
Group type: EXPERIMENTAL
Intervention: CALMA intervention (culturally adapted family asthma management intervention)
Number of subjects: 0
Study 18061648 — intervention group
Group type: EXPERIMENTAL
Intervention: CALMA intervention
Number of subjects: 0
Study 18061648 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 17216727 — intervention group
Group type: EXPERIMENTAL
Intervention: Saccharine (22.5 mg)
Number of subjects: 1
Study 17216727 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of saccharine (22.5 mg) and cyclamate (150 mg)
Number of subjects: 1
Study 17216727 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study 14584388 — intervention group
Group type: EXPERIMENTAL
Intervention: Pranlukast therapy for 4 weeks, continued for Group I for an additional two years.
Number of subjects: 81
Study 14584388 — intervention group
Group type: EXPERIMENTAL
Intervention: Pranlukast therapy continued for Group II for one more year after showing a 5% or greater increase in PEFR after one year.
Number of subjects: 81
Study 14584388 — intervention group
Group type: COMPARATOR
Intervention: Medication was suspended for Group III after failing to show improvement in PEFR after one year.
Number of subjects: 81
Study 11068313 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage T1c cancer
Number of subjects: 720
Study 11068313 — intervention group
Group type: COMPARATOR
Intervention: Stage T2 cancer diagnosed in the pre-PSA era
Number of subjects: 720
Study 11068313 — intervention group
Group type: COMPARATOR
Intervention: Men without cancer
Number of subjects: 720
Study 8879928 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% isoeugenol in ethanol (ROAT)
Number of subjects: 19
Study 8879928 — intervention group
Group type: EXPERIMENTAL
Intervention: Patch testing with serial dilutions of isoeugenol
Number of subjects: 19
Study 8879928 — intervention group
Group type: EXPERIMENTAL
Intervention: Use testing on the neck for 14 days
Number of subjects: 19
Study 8879928 — intervention group
Group type: EXPERIMENTAL
Intervention: Patch testing with isoeugenol
Number of subjects: 19
Study 1552037 — intervention group
Group type: EXPERIMENTAL
Intervention: General Inquiry method
Number of subjects: 0
Study 1552037 — intervention group
Group type: COMPARATOR
Intervention: Specific Inquiry method
Number of subjects: 0
Study 3894338 — intervention group
Group type: EXPERIMENTAL
Intervention: Molindone hydrochloride
Number of subjects: 31
Study 3894338 — intervention group
Group type: COMPARATOR
Intervention: Thioridazine
Number of subjects: 31
Study 31404547 — intervention group
Group type: EXPERIMENTAL
Intervention: Tweeting via TSSMN
Number of subjects: 112
Study 31404547 — intervention group
Group type: COMPARATOR
Intervention: Control (non‐tweeted) group
Number of subjects: 112
Study 30654471 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard in Lab (SL) protocol
Number of subjects: 18
Study 30654471 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbreviated in Lab (AL) protocol
Number of subjects: 18
Study 30654471 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbreviated with Freedom (AF) protocol
Number of subjects: 18
Study 27853876 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent non-invasive ventilation (NIV)
Number of subjects: 16
Study 27853876 — intervention group
Group type: COMPARATOR
Intervention: Control group (no NIV)
Number of subjects: 16
Study 26427960 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Body Vibration Exercise (WBVE) + Quadriceps Resistance Exercise (QRE)
Number of subjects: 99
Study 24370760 — intervention group
Group type: EXPERIMENTAL
Intervention: Talk Test (TT)
Number of subjects: 64
Study 23091101 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab every 2 months for 1 year
Number of subjects: 477